Norway· NO-ID_A7C27ADC-662C-4E88-8D9A-185837C061B7
Aureomycin
A chlortetracycline product containing chlortetracycline hydrochloride, registered in Norway. The same ATC class is registered in 4 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Chlortetracycline is registered in 4 of 19 countries.
Countries holding a registration under ATC S01AA02 (chlortetracycline), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 3 of them publish a price we can compare per daily dose
Chlortetracycline · ATC S01AA02
4 / 19 countries
- Belgiumprice
- Finlandprice
- Norwayprice
- United Kingdom
The record
At a glance
FEST (Norway)- Active substance
- Chlortetracycline Hydrochloride
- Manufacturer
- —
- Country
- Norway (NO)
- ATC code
- S01AA02
- ATC class
- Chlortetracycline
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_A7C27ADC-662C-4E88-8D9A-185837C061B7
- no_varenummer2678225
- gtin3400934213342
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlortetracycline in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAureomycinWyeth Lederle Nordiska Ab
- CanadaAUREOMYCIN 220 GZOETIS CANADA INC
- FranceAUREOMYCINE EVANS 1 POUR CENT, pommade ophtalmiqueSCA PHARMA
- SpainDERMOSA AUREOMICINA 10 MG/G POMADATeofarma S.R.L.
- BelgiumAureomycin 1 %BePharBel Manufacturing
- PolandChlorocyclinum 3%Chema-Elektromet Spółdzielnia Pracy
- GermanyAureomycinAbanta Pharma Gmbh
- United KingdomAureomycine Evans 1% eye ointmentImported (France)
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Belgium · Aureomycin
- Germany · Aureomycin
- Spain · Dermosa Aureomicina, Oftalmolosa Cusí Aureomicina
- France · Aureomycine Evans
- Italy · Aureomicina
- Luxembourg · Aureomycin
- Poland · Chlorocyclinum 3 %
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dd77d3e8-519e-43cc-b20f-58b3c1fbcc14 GET /v1/drugs/dd77d3e8-519e-43cc-b20f-58b3c1fbcc14?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Øyesalve",
"source": "fest",
"status": "A",
"atc_name": "Klortetrasyklin",
"merkevare_id": "ID_A7C27ADC-662C-4E88-8D9A-185837C061B7",
"name_form_strength": "Aureomycin øyesalve 1 %",
"prescription_group": "C"
}See everything about chlortetracycline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.